Chronic obstructive pulmonary disease. Mechanisms of disease development and prevention strategies with antioxidants.
Authors
Daga Mk; Vallyathan V
Source
Oxygen/nitrogen radicals: lung injury and disease (Lung biology in health and disease). Vallyathan V, Castranova V, Shi X, eds. New York: Marcel Dekker, 2004 Apr; 187:361-391
Link
NIOSHTIC No.
20025838
Abstract
To summarize, one can say with certainty that COPD develops in genetically susceptible individuals after prolonged exposure to cigarette smoke. Presently, most of the genes contributing to this are unknown. Alpha1-A T deficiency is a risk factor for COPD, but other genetic associations with this disease must still be considered as tentative. The key to establishing that a gene modifies the risk for a disease is replication of the association in different populations. This is a difficult task. Besides alpha1-AT, only the GST-Ml, VDBP, and CFTR genes have been implicated as risk factors in more than one population. Identification of other candidate genes would further enhance the understanding of COPD pathogenesis at the molecular level. There is also good evidence that the propensity to smoke cigarettes and the likelihood of quitting smoking are influenced by genetic factors. This can be useful in efforts directed at cessation of smoking. The responses to hypoxia and hypercapnia also seem to be influenced by genetic factors. Identification of the genes involved could yield important insights into the pathogenesis of COPD and provide new targets for therapeutic interventions for this debilitating disease.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.